Monitor for the announcement of a definitive business combination target. The SPAC has a 24-month deadline (October 2028) and a forward purchase agreement providing up to $25M in additional deal financing.
Price Chart
Executive Summary
This 8-K reports the consummation of Frazier Life Sciences Acquisition Corp. II's IPO on October 15, 2026, and provides an audited balance sheet as of that date. The SPAC raised $75 million in gross proceeds from 7.5 million public units at $10.00 each, plus $3 million from a concurrent private placement. The filing is a routine post-IPO administrative update with no material new information beyond confirming the trust account funding.
Key Facts
- IPO of 7,500,000 Class A ordinary shares at $10.00 per share closed on October 15, 2026, generating $75,000,000 in gross proceeds.
- Concurrent private placement of 300,000 Class A ordinary shares to the sponsor at $10.00 per share generated $3,000,000.
- Total of $75,000,000 deposited in a trust account for the benefit of public shareholders.
- The SPAC has 24 months from the IPO closing to complete a business combination or it will liquidate.
- A forward purchase agreement with an affiliate commits up to $25,000,000 in additional capital at the time of a business combination.
Financial Impact
IPO gross proceeds of $75,000,000 plus $3,000,000 private placement, with $75,000,000 held in trust. Working capital outside trust is $1,773,528.
Risk Factors
- No target identified yet; failure to complete a business combination within 24 months would result in liquidation at ~$10.00 per share.
- Sponsor indemnification of the trust account may be insufficient as sponsor's only assets are securities of the company.
- Shareholder redemptions could reduce trust account proceeds available for a deal.
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-429129 |
| Document: d430914d8k.htm | 0001193125-26-429129 |
| Document: 0001193125-26-429129-index-headers.html | 0001193125-26-429129 |
| Document: 0001193125-26-429129-index.html | 0001193125-26-429129 |
| Document: 0001193125-26-429129.txt | 0001193125-26-429129 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $10.30 | awaiting T+5 | — | $10.28 (−0.19%) |
Oct 22, 2026 4d ago | SC 13G | $10.30 | awaiting T+5 | — | $10.28 (−0.19%) |
Oct 21, 2026 5d ago | SC 13D | $10.27 | awaiting T+5 | — | $10.28 (+0.10%) |
Oct 21, 2026 5d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.28 (+0.10%) |
Oct 21, 2026 5d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.28 (+0.10%) |
Oct 16, 2026 10d ago | SC 13G | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.28 (−0.68%) |
Oct 15, 2026 11d ago | Insider Buy | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.28 (−0.68%) |
Oct 15, 2026 11d ago | 8-K | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.28 (−0.68%) |
Oct 14, 2026 12d ago | 424B4 | $10.49 $10.27 | ▼ −2.10% | ▼ −1.08% | $10.28 (−2.00%) |
Oct 14, 2026 12d ago | EFFECT | $10.29 $10.30 | ▲ +0.10% | ▼ −0.36% | $10.28 (−0.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers